抗体

  • Slogan Icon High Specificity & Affinity
  • Slogan Icon Consistent Quality Across Batches
  • Slogan Icon Rigorous Validation Standards
  • Slogan Icon Flexible Customization & Delivery

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a "Y" shaped structure. Both tips of the "Y" structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.

Antibody Customization Service

  • Mature Development Platform
  • Personalized customization
  • Diverse verification & testing platforms
  • Flexible delivery modes

Covering polyclonal to recombinant monoclonal antibodies, we deliver complete solutions to satisfy your R&D demands.Our well-established biopharmaceutical ecosystem enables seamless project advancement from discovery to commercialization, reducing process handovers, saving time and ensuring consistent outcomes.

Comprehensive Validation System

  • Extensive Sample Library

    • 

    Small-molecule compound–treated samples

    • 

    KO/KD validation samples

    • 

    Samples treated with signaling pathway modulators

    • 

    Recombinant protein and peptide samples

    • 

    Multi-species tissue samples

    • 

    Multi-species cell samples

    • 

    Tissue Microarray (TMA)

  • Comprehensive Systematic Quality Control

    • 

    Empty vector controls

    • 

    Isotype controls

    • 

    Multiple experimental conditions

    • 

    Comparison with validated reference antibodies

    • 

    Batch-to-batch consistency validation

    • 

    Stability assessment

  • Multi-Dimensional Validation

    • 

    Genetic modulation validation

    • 

    Small-molecule intervention validation

    • 

    Drug treatment validation

    • 

    Multi-center independent validation

  • Global Validation

    • 

    (IF=52.7) Signal Transduct Target Ther. 2026 Mar 16;11(1):96.

    • 

    (IF=52.7) Signal Transduct Target Ther. 2025 Nov 18;10(1):373.

    • 

    (IF=52.7) Signal Transduct Target Ther. 2025 Jul 9;10(1):217.

    • 

    (IF=45.8) Science. 2026 Mar 19;391(6791):eadu7686.

    • 

    (IF=42.5) Cell. 2026 Apr 2;189(7):1923-1941.e26.

    • 

    (IF=42.5) Cell. 2026 Apr 2;189(7):1942-1956.e26.

  • HY-P84242

    ADORA2A Antibody
    (YA3939)

  • HY-P82131

    Cytokeratin 14 Antibody
    (YA1876)

  • HY-P80079

    CDK6 Antibody
    (YA511)

  • HY-P86421

    Bcl-2 Antibody
    (YA6113)

  • HY-P80003

    Bad Antibody
    (YA593)

  • HY-P80036

    BRAF Antibody
    (YA820)

Reference compunds molecules combination validation

  • HY-12320 Cycloheximide
    HY-P83705 MDM2 Antibody (YA3442)
    HY-P80626 c-Myc Antibody (YA497)
    HY-P80438 Beta Actin Antibody (YA823)
  • HY-145703 SHP2-D26 isomer-1
    HY-P81898 SHP2 Antibody (YA1643)
  • HY-15763 Erastin
    HY-P80450 GPX4 Antibody (YA399)
    HY-P80137 GAPDH Antibody (YA418)
  • HY-144315 CYD19
    HY-P81135 SNAI1 Antibody
  • HY-12320 Cycloheximide
    HY-P83705 MDM2 Antibody (YA3442)
    HY-P80626 c-Myc Antibody (YA497)
    HY-P80438 Beta Actin Antibody (YA823)
  • HY-17559 Actinomycin D
    HY-P83705 MDM2 Antibody (YA3442)
    HY-P80938 p53 Antibody
    HY-P80137 GAPDH Antibody (YA418)
  • HY-P81898 SHP2 Antibody (YA1643)
  • HY-100218A RSL3
    HY-P80450 GPX4 Antibody (YA399)
    HY-P80137 GAPDH Antibody (YA418)

KO/KD validation

  • HY-P80430
    PKC alpha Antibody (YA131)
  • HY-P80478
    Phospho-STAT1 (Ser727) Antibody (YA148)
  • HY-P80784
    PGK1 Antibody
  • HY-P80206A
    LAMP1 Antibody (YA3434)
  • HY-P80372
    Vinculin Antibody (YA010)
  • HY-P80546
    Argonaute 2 Antibody
  • HY-P80570
    beta III Tubulin Antibody (YA586)

Comparison with validated reference antibodies

  • HY-P80450
    GPX4 Antibody (YA399)
    Competitor
  • HY-P87903
    Cleaved PARP1 Antibody (YA7588)
    Competitor
  • HY-P86409
    Arginase-1 Antibody (YA6101)
    Competitor
  • HY-P80566
    Bcl-2 Antibody (YA590)
    Competitor
  • HY-P80902
    STAT3 Antibody (YA666)
    Competitor
  • HY-P80319
    SIRT1 Antibody (YA082)
    Competitor

Comparison with validated reference antibodies

  • HY-P80450 GPX4
    Antibody(YA399)
    Competitor
  • HY-P86421
    Bcl-2 Antibody(YA6113)
    Competitor
  • HY-P80319 SIRT1
    Antibody(YA082)
    Competitor
  • HY-P80263 PARP1
    Antibody(YA246)
    Competitor
  • HY-P81098
    CD34 Antibody
    Competitor
  • HY-P80841 Phospho-Nrf2
    (Ser40) Antibody(YA169)
    Competitor

  • Manufacturing Batch-to-Batch Consistency Validation

    Lot1 Lot2
    HY-P81270
    DNA PKcs Antibody
    (YA957)
    HY-P80914
    TNF alpha Antibody
    HY-P80350
    STING Antibody
    (YA048)

  • Independent Validation Across Multiple R&D Centers

    Lab1 Lab2
    HY-P80025
    Bad Antibody
    (YA593)
    HY-P80068
    CD9 Antibody(YA524)

Stability Validation

Condition 1 Condition 2 Condition 3 Condition 4 Condition 5 Condition 6

HY-P87903 Cleaved PARP1 Antibody (YA7588)

ホットトピック

Antibody Application Technology Resources

More